Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of ConcernsMartín A. Rossotti(National Research Council Canada), Jamshid Tanha(University of Ottawa)bioRxiv (Cold Spring Harbor Laboratory)December 21, 202110.1101/2021.12.20.473401Cited by 2SaveCiteExport RISWatch citationsRelated PapersCamelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling|Biochemical Journal|2018|32Optimization of synthetic human <scp>V<sub>H</sub></scp> affinity and solubility through in vitro affinity maturation and minimal camelization|Protein Science|2025|5A Safe and Accessible Cell-Based Spike–ACE2 Binding Assay for Evaluating SARS-CoV-2 Neutralization Activity in Biological Samples Using Flow Cytometry|Methods and Protocols|2025|0